Digoxin: Difference between revisions
Line 15: | Line 15: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
'''| [[ | ===DIGOXIN injection<sup>®</sup>=== | ||
'''| [[ | '''| [[DIGOXIN injection indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[DIGOXIN injection dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[DIGOXIN injection dosage forms and strengths|Dosage Forms and Strengths]]''' | ||
'''| [[ | '''| [[DIGOXIN injection contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[DIGOXIN injection warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[DIGOXIN injection adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[DIGOXIN injection drug interactions|Drug Interactions]]''' | ||
'''| [[ | '''| [[DIGOXIN injection use in specific populations|Use in Specific Populations]]''' | ||
'''| [[ | '''| [[DIGOXIN injection overdosage|Overdosage]]''' | ||
'''| [[ | '''| [[DIGOXIN injection description|Description]]''' | ||
'''| [[ | '''| [[DIGOXIN injection clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[DIGOXIN injection nonclinical toxicology|Nonclinical Toxicology]]''' | ||
'''| [[ | '''| [[DIGOXIN injection clinical studies|Clinical Studies]]''' | ||
'''| [[ | '''| [[DIGOXIN injection how supplied storage and handling|How Supplied/Storage and Handling]]''' | ||
'''| [[ | '''| [[DIGOXIN injection patient counseling information|Patient Counseling Information]]''' | ||
'''| [[DIGOXIN injection labels and packages|Labels and Packages]]''' | |||
===DIGOXIN tablet<sup>®</sup>=== | |||
'''| [[DIGOXIN tablet indications and usage|Indications and Usage]]''' | |||
'''| [[DIGOXIN tablet dosage and administration|Dosage and Administration]]''' | |||
'''| [[DIGOXIN tablet dosage forms and strengths|Dosage Forms and Strengths]]''' | |||
'''| [[DIGOXIN tablet contraindications|Contraindications]]''' | |||
'''| [[DIGOXIN tablet warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[DIGOXIN tablet adverse reactions|Adverse Reactions]]''' | |||
'''| [[DIGOXIN tablet drug interactions|Drug Interactions]]''' | |||
'''| [[DIGOXIN tablet use in specific populations|Use in Specific Populations]]''' | |||
'''| [[DIGOXIN tablet overdosage|Overdosage]]''' | |||
'''| [[DIGOXIN tablet description|Description]]''' | |||
'''| [[DIGOXIN tablet clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[DIGOXIN tablet nonclinical toxicology|Nonclinical Toxicology]]''' | |||
'''| [[DIGOXIN tablet clinical studies|Clinical Studies]]''' | |||
'''| [[DIGOXIN tablet how supplied storage and handling|How Supplied/Storage and Handling]]''' | |||
'''| [[DIGOXIN tablet patient counseling information|Patient Counseling Information]]''' | |||
'''| [[DIGOXIN tablet labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | ==Mechanism of Action== |
Revision as of 19:25, 27 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here.
Overview
Digoxin INN is a purified cardiac glycoside similar to Digitoxin extracted from the foxglove plant, Digitalis lanata,[1] which was discovered by William Withering. Its corresponding aglycone is digoxigenin, and its acetyl derivative is acetyldigoxin. Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication.
Category
Cardiac glycosides.
US Brand Names
LANOXIN®, DIGOXIN®
FDA Package Insert
DIGOXIN injection®
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
DIGOXIN tablet®
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
- ↑ Hollman A (1996). "Digoxin comes from Digitalis lanata". British Medical Journal. 312 (7035): 912.